SCOPUS 정보 검색 플랫폼

Volumn 268, Issue 7187, 2002, Pages 300-301

Biopharmaceutical molecules are not created equally

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; AMINO ACID; ANTIBODY; BETA INTERFERON; BETA1A INTERFERON; BIOLOGICAL PRODUCT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; CYTOKINE; DISULFIDE; ERYTHROPOIETIN; FIBRINOLYTIC AGENT; GENERIC DRUG; GROWTH HORMONE; HORMONE; HUMAN SERUM ALBUMIN; HYBRID PROTEIN; INSULIN; INTERLEUKIN 2; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; PROTEIN; SUGAR;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ANALYSIS; DRUG CHOICE; DRUG INDICATION; DRUG MARKETING; DRUG RESPONSE; DRUG SAFETY; GENE SEQUENCE; HEPATITIS B; HEPATITIS C; IMMUNOGENICITY; MULTIPLE SCLEROSIS; PATENT; PHARMACEUTICS; PHARMACOKINETICS;

EID: 0037006580 PISSN: 00316873 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (6)

References (13)

1
- 0006428778
- Monoclonal antibodies
- Stein S, editor. New York: Marcel Dekker
- (1990) Fundamentals of Protein Biotechnology
- Bausch, J.N.¹

2
- 0013060318
- Storage stabilization of proteins
- Franks F, editor. New Jersey: The Humana Press
- (1993) Protein Biotechnology.
- Franks, F.¹

3
- 0028329096
- An enzyme-linked immunosorbant assay (ELISA) for quantitation of adducts of granulocyte-macrophage colony stimulating factor (GM-CSF) and human serum albumin (HSA) in stressed solution mixtures
- (1994) Pharm. Res. , vol.11 , pp. 365-371
- Kumarasamy, R.¹ Bausch, J.² Kopcha, D.³ Patel, S.⁴ McGonigle, E.⁵

4
- 0030742739
- In vivo development of antibodies to interferons: An update to 1996
- (1997) J. Interferon. Cytokine Res. , vol.17
- Antonelli, G.¹

5
- 0030857343
- The expression of potency of neutralizing antibodies for interferons and other cytokines
- (1997) Biotherapy , vol.10-11 , pp. 93-98
- Grossberg, S.E.¹ Kawade, Y.²

6
- 0030838371
- Assays for antibodies to human interferon-alpha: The need for standardisation
- (1997) J. Interferon Cytokine Res. , vol.17
- Schellekens, H.¹ Ryff, J.-C.² Van Der Meide, P.H.³

7
- 0025759062
- Neutralising antibodies to interferon alpha: Relative frequency in patients treated with different interferon preparations
- (1991) J. Infect. Dis. , vol.163 , pp. 882-885
- Antonelli, G.¹ Currenti, M.² Turriziani, O.³ Dianzani, F.⁴

8
- 0030803840
- Interferon immunogenicity: Technical evaluation of interferon alpha-2a
- (1997) J. Interferon Cytokine Res. , vol.17
- Hochuli, E.¹

9
- 0030740864
- Interferon immunogenicity: Preclinical evaluation of interferon alpha-2a
- (1997) J. Interferon Cytokine Res. , vol.17
- Palleroni, A.V.¹ Aglione, A.² Labow, M.³ Brunda, M.J.⁴ Pestka, S.⁵ Sinigaglia, F.⁶

10
- 0030754581
- Clinical investigation of immunogenicity of interferon alpha-2a
- (1997) J. Interferon Cytokine Res. , vol.17
- Ryff, J.-C.¹

11
- 0008678962
- Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
- The Multiple Sclerosis Collaborative Research Group (MSCRG).
- (1996) Ann. Neurol. , vol.39 , pp. 285-294
- Jacobs, L.D.¹ Cookfair, D.L.² Rudick, R.A.³ Herndon, R.M.⁴ Richert, J.R.⁵ Salazar, A.⁶

12
- 0002145306
- Results of an ongoing, open-label, safety-extension study of interferon beta-1a (Avonex) treatment in multiple sclerosis
- Available at (accessed 21 February 2002).
- (1999) Int. J. MS Care
- Herndon, R.M.¹ Jacobs, L.D.² Coats, M.E.³ Goodkin, D.E.⁴ Mass, M.K.⁵ Richert, J.R.⁶

13
- 0036591653
- Immunogenicity of rDNA derived pharmaceuticals: Guidelines
- In press.
- (2002) Trends Pharmacol. Sci.
- Ryff, J.-C.¹ Schellekens, H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.